Life Sciences
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.
The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.
Also: Imagene AI raises $21.5 million across two rounds for precision cancer care, and Capable Health scores $6 million in seed funding to help providers build healthcare apps.
In one large-scale study, mean engagement with the app lasted only 4.1 days.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
The collection by Getlabs will cost users a convenience fee starting at $25.
The company, which uses artificial intelligence to make sense of unstructured clinical information like EHR data, raised $18 million in June 2021.